By integrating real-world data more deeply into the process of clinical research, life sciences stakeholders can open up new possibilities for therapeutic development and the evidence-based treatment of hematologic cancers.
C.K. Wang, MD
Advertisement
Chief Medical Officer at COTA, Inc.
Articles by C.K. Wang, MD
Advertisement
Latest Updated Articles
Real-World Data Offers Significant Opportunities for Developing New Therapies for Hematologic CancersPublished: May 2nd 2022 | Updated:
Utilizing Real-World Data in OncologyPublished: September 30th 2025 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: AI, Equity, and Innovation Drive Clinical Research Forward
2
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
3
Reducing Site Burden Through Better Technology Integration in Clinical Trials
4
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
